0001127602-22-000457.txt : 20220104
0001127602-22-000457.hdr.sgml : 20220104
20220104161953
ACCESSION NUMBER: 0001127602-22-000457
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211231
FILED AS OF DATE: 20220104
DATE AS OF CHANGE: 20220104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McMillan Wayde D.
CENTRAL INDEX KEY: 0001768648
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33462
FILM NUMBER: 22506237
MAIL ADDRESS:
STREET 1: C/O INSULET CORPORATION
STREET 2: 100 NAGOG PARK
CITY: ACTON
STATE: MA
ZIP: 01720
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSULET CORP
CENTRAL INDEX KEY: 0001145197
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043523891
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 NAGOG PARK
CITY: ACTON
STATE: MA
ZIP: 01720
BUSINESS PHONE: 978-600-7000
MAIL ADDRESS:
STREET 1: 100 NAGOG PARK
CITY: ACTON
STATE: MA
ZIP: 01720
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-12-31
0001145197
INSULET CORP
PODD
0001768648
McMillan Wayde D.
C/O INSULET CORPORATION
100 NAGOG PARK
ACTON
MA
01720
1
EVP, CFO
Common Stock
2021-12-31
4
S
0
193
266.37
D
21740
D
Common Stock
2021-12-31
4
S
0
400
267.82
D
21340
D
Common Stock
2021-12-31
4
S
0
500
268.88
D
20840
D
Common Stock
2021-12-31
4
S
0
672
270.19
D
20168
D
Common Stock
2021-12-31
4
S
0
90
271.23
D
20078
D
The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan.
The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $266.04 to $266.54. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $267.45 to $268.11. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $268.47 to $269.36. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $269.86 to $270.55. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
/s/ John W. Kapples, attorney-in-fact
2022-01-04